A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke
Mark Parsons, Neil Spratt, Andrew Bivard, Bruce Campbell, Kong Chung, Ferdinand Miteff, Bill O'Brien, Christopher Bladin, Patrick McElduff, Chris Allen, Grant Bateman, Geoffrey Donnan, Stephen Davis, Christopher Levi
New England Journal of Medicine | MASSACHUSETTS MEDICAL SOC | Published : 2012
Supported by a grant from the Australian National Health and Medical Research Council.Dr. Parsons reports receiving advisory-board fees from Bayer Australia; Dr. Campbell, consultancy fees from Lundbeck, speaker payments from Boehringer Ingelheim Australia, and grant support from Cardiovascular Lipid Australia; Dr. Bladin, advisory-board fees from Bayer Australia; Dr. Donnan, consultancy fees from Boehringer Ingelheim Australia and Bayer Australia; Dr. Davis, consultancy fees from Orsan Technologies and Ever Pharma; and Dr. Levi, consultancy fees from Boehringer Ingelheim Australia. No other potential conflict of interest relevant to this article was reported.